Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Ductal Adenocarcinoma × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 16 Breast Neoplasms 15 Pain 9 Agnosia 6 Prostatic Neoplasms 5 Lung Neoplasms 5 Neoplasms 4 Stomach Neoplasms 3 Postoperative Complications 3 Colonic Neoplasms 3 Supratentorial Neoplasms 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Sleep Deprivation 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningioma 1 Malignant Neoplasms of Male Genital Organs 1 Liver Neoplasms 1 Liver Diseases 1

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 3 Pancreaticoduodenectomy 2 Oxaliplatin 2 Irinotecan 2 titanium silicide 1 tislelizumab 1 sonidegib 1 paricalcitol 1 mitazalimab 1 lenvatinib 1 ivosidenib 1 glucoraphanin 1 devimistat 1 Transurethral Resection of Prostate 1 Tissue Banks 1 Taxes 1 Specimen Handling 1 Saline Solution 1 S 1 (combination) 1 Ropivacaine 1 Robotic Surgical Procedures 1 Positron Emission Tomography Computed Tomography 1 Parturition 1 PEGPH20 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Losartan 1 Leucovorin 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06214533 2024-01-19

CEBOIDS

Sixth Affiliated Hospital, Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡